Literature DB >> 12036323

Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.

Robbert G van der Most1, Laurie E Harrington, Vicki Giuggio, Patryce L Mahar, Rafi Ahmed.   

Abstract

The yellow fever virus 17D vaccine strain is one of the most effective and safe vaccines available. The immune response after immunization is characterized by long-lasting high titers of neutralizing antibodies. Here, we have initiated a characterization of YFV-17D-specific cellular immune responses. This study makes three points. First, we have identified two CD8 T cell epitopes and one CD4 T cell epitope. An H-2Kb-restricted dominant epitope was mapped in the NS3 protein, whereas the viral envelope protein harbored an H-2Db-restricted subdominant epitope and the I-Ab-restricted CD4 T cell epitope. Second, illustrating the concept of immunodomination, we found that after abrogation of the dominant response in H-2Kb knockout mice, the frequencies of T cells recognizing the subdominant Db-restricted epitope increased dramatically. Finally, the H-2Db-restricted epitope lacks the canonical Asn anchor residue at position 5, indicating that epitopes may be missed by strict application of the H-2Db-binding motif. Identification of these T cell epitopes will facilitate studies on the cellular immunity against YFV-based expression or immunization vectors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036323     DOI: 10.1006/viro.2002.1432

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells.

Authors:  Nelson B Moseley; Oskar Laur; Chris C Ibegbu; Gilbert D Loria; Gini Ikwuenzunma; Himangi R Jayakar; Michael A Whitt; John D Altman
Journal:  J Immunol Methods       Date:  2011-10-08       Impact factor: 2.303

3.  CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.

Authors:  Lauren E Yauch; Tyler R Prestwood; Monica M May; Malika M Morar; Raphaël M Zellweger; Bjoern Peters; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

4.  Structural Basis for CD4+ T Cell Epitope Dominance in Arbo-Flavivirus Envelope Proteins: A Meta-Analysis.

Authors:  Samuel J Landry; Daniel L Moss; Da Cui; Ryan P Ferrie; Mitchell L Fullerton; Evan A Wells; Lu Yang; Nini Zhou; Thomas Dougherty; Ramgopal R Mettu
Journal:  Viral Immunol       Date:  2017-06-14       Impact factor: 2.257

Review 5.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

6.  Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.

Authors:  María C Jaimes; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  CD4+ T-cell epitope prediction using antigen processing constraints.

Authors:  Ramgopal R Mettu; Tysheena Charles; Samuel J Landry
Journal:  J Immunol Methods       Date:  2016-02-15       Impact factor: 2.303

8.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Authors:  Petr Danecek; Wenzhe Lu; Catherine H Schein
Journal:  J Mol Biol       Date:  2009-12-04       Impact factor: 5.469

10.  Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.

Authors:  Soumitra Roy; Gary P Kobinger; Jianping Lin; Joanita Figueredo; Roberto Calcedo; Darwyn Kobasa; James M Wilson
Journal:  Vaccine       Date:  2007-08-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.